Pharmaceutical products

Tender description

NHS National Framework Agreement for the supply of Recombinant Von Willebrand Factor. The framework will commence on 1 February 2021 for a period of 5 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 43 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the invitation to offer documents for the list of purchasing points. NHS National Framework Agreement for the supply of Recombinant Von Willebrand Factor. The framework will commence on 1 February 2021 for a period of 5 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 43 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the invitation to offer documents for the list of purchasing points.